This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Array Biopharma Inc., Genentech, Inc.. Active years: 2019-2020.
Location History:
- Boulder, CO (US) (2019)
- Loveland, CO (US) (2020)
Company Filing History:
2 out of 333 
1 out of 3,298 
Years Active: 2019-2020
Title: Innovations of Zackary D Crane
Introduction
Zackary D Crane is an accomplished inventor based in Boulder, CO. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 2 patents, his work focuses on addressing various medical conditions through innovative compounds.
Latest Patents
One of Zackary's latest patents is a compound identified as ((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea, which serves as a TrkA kinase inhibitor. This compound is particularly useful in treating diseases such as pain, cancer, inflammation, neurodegenerative diseases, and various other conditions related to TrkA kinase activity. Additionally, he has developed processes for preparing compounds that can be utilized as CHK1 inhibitors.
Career Highlights
Zackary has worked with notable companies in the pharmaceutical industry, including Array Biopharma Inc. and Genentech, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Zackary has collaborated with talented individuals such as Weidong Liu and Shelley Allen. These partnerships have enhanced his research and development efforts, leading to impactful inventions.
Conclusion
Zackary D Crane's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.